PYXS — Pyxis Oncology Share News
0.000.00%
Last trade - 00:00- $200.90m
- $167.90m
- $13.86m
Brief: Pyxis Oncology Initiates New PYX-201 Combination Trial and Initiates Cohort Expansions of Ongoing Monotherapy Trial
Brief: Pyxis Oncology Announces Portfolio Prioritization, Focusing Resources On Its Lead Clinical Program, Pyx-201
U.S. RESEARCH ROUNDUP-Microstrategy, Snowflake, Target
Brief: Pyxis Oncology Announces Favorable Preliminary PYX-201 Clinical Phase 1 Part 1 Data
Brief: Pyxis Oncology Q3 Net Income USD -21.203 Million Vs. IBES Estimate USD -19.2 Million
Pyxis Oncology Inc reports results for the quarter ended in January - Earnings Summary
Brief: Pyxis Oncology Q2 Net Income USD -17.301 Million Vs. IBES Estimate USD -18.8 Million
Pyxis Oncology Inc expected to post a loss of 32 cents a share - Earnings Preview
Brief: Pyxis Oncology Expands Board Of Directors With Appointment Of Michael A. Metzger
Pyxis Oncology Inc reports results for the quarter ended in March - Earnings Summary
Brief: Pyxis Oncology Q1 Net Income USD -3.256 Million Vs. IBES Estimate USD -13 Million
Pyxis Oncology Inc expected to post a loss of 25 cents a share - Earnings Preview
Brief: Pyxis Oncology Inc Files For Resale Of Up To 10.5 Million Shares By The Selling Stockholders - SEC Filing
Brief: Pyxis Oncology Obtains $8 Mln Payment For Sale Of Royalty Rights
Pyxis Oncology Inc reports results for the quarter ended in December - Earnings Summary
Brief: Pyxis Oncology FY Net Income USD -73.79 Million
Pyxis Oncology Inc expected to post a loss of 47 cents a share - Earnings Preview
Brief: Pyxis Oncology Appoints Santhosh Palani To Board
Brief: Pyxis Oncology Announces $50 Million Private Placement